Daprodustat dose was increased by week 12 in the tertile 2 and 3 ERI subgroups. Daprodustat median dose during weeks 40–52 were 4.0 mg, 6.0 mg, and 6.0 mg for the tertile 1, 2, and 3 ERI subgroups, respectively. Error bars represent 25th percentile, 75th percentile for median dose. Median dose by ERI subgroup of darbepoetin alfa was a post hoc analysis. ERI, erythropoietin resistance index; W, week.